CEO Professor Alan Trounson AO said, “The successful capital raising, in times of scant investment support in biotechnology, is welcome and further supports confidence in the company for the delivery of effective therapies in ovarian cancer and other difficult diseases.” …
Latest Video
New Stories
-
Nobody can possibly sustain an argument this is not a price negotiation
August 15, 2025 - - Latest News -
When it comes to PBAC outcomes, it's all in the language, about pricing
August 15, 2025 - - Latest News -
Interim report calls for prevention focus to boost the nation's productivity
August 14, 2025 - - Latest News -
Just because the system involves humans, it does not make it human
August 14, 2025 - - Latest News -
Australian company Mirugen secures backing to process cell technology
August 13, 2025 - - Latest News -
AccessCR’s awards celebrate partnerships between lived experience and science
August 13, 2025 - - Latest News -
Firebrick says Nasodine COVID-19 patent accepted in Europe
August 13, 2025 - - Australian Biotech